🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Cathie Wood's ARK sells Tesla, buys more Archer Aviation stock

Published 10/30/2024, 08:02 AM
© Reuters.
TSLA
-
AIR
-

Cathie Wood's ARK ETFs have made their daily trades for Tuesday, October 29th, 2024, with significant activity across a range of innovative companies. In a notable move, ARK sold 13,896 shares of Tesla Inc (NASDAQ:TSLA) from its ARKK and ARKW ETFs, valued at approximately $3.65 million, making it the largest dollar-value trade of the day.

On the buying side, ARK's ARKK ETF purchased a substantial 830,130 shares of Archer Aviation Inc (NYSE:NYSE:ACHR), totaling around $2.83 million. This continues a trend for ARK, which also added a significant number of ACHR shares on Monday. Similarly, ARK's ARKG ETF increased its position in Absci Corp (NASDAQ:ABSI) by buying 446,810 shares, worth about $1.92 million, adding to Monday's purchase.

ARK's ARKG ETF also sold 125,666 shares of CareDx Inc (NASDAQ:CDNA), amounting to roughly $2.88 million, which represents the second-largest trade by dollar value for the day. Additionally, the ETF offloaded 87,766 shares of Nurix Therapeutics Inc (NASDAQ:NRIX) for approximately $2.32 million.

Other significant buying activities include the acquisition of 298,188 shares of Cerus Corp (NASDAQ:CERS) through ARKK and ARKG ETFs, valued at around $512,883, and the purchase of 37,281 shares of Beam Therapeutics Inc (NASDAQ:BEAM) for about $833,230 through the ARKK ETF.

ARK's ARKG ETF bought 22,142 shares of Illumina Inc (NASDAQ:ILMN), while ARKK and ARKW ETFs together acquired 1,642 shares of Meta Platforms Inc (NASDAQ:META), totaling $949,338. The ARKK ETF also added 8,326 shares of Natera Inc (NASDAQ:NTRA), worth approximately $1.01 million.

Smaller trades included the purchase of 81,626 shares of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) and 14,058 shares of Tempus AI Inc (NYSE:TEM), as well as the acquisition of 7,994 shares of Twist Bioscience Corp (NASDAQ:TWST).

On the selling front, ARK's ARKF ETF divested 16,396 shares of Robinhood Markets Inc (NASDAQ:HOOD), and ARKG ETF sold 615,604 shares of Standard Biotools Inc (NASDAQ:LAB) and 23,013 shares of Moderna Inc (NASDAQ:MRNA). The ARKK ETF parted with 11,2973 shares of Unity Software Inc (NYSE:U).

These transactions reflect ARK's ongoing strategy to invest in disruptive innovation while adjusting its portfolio in response to market developments. Investors following ARK's trades will note the continued interest in biotech and healthcare, alongside adjustments in tech and aerospace holdings.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.